Viewing Study NCT01195259


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2026-02-02 @ 5:23 PM
Study NCT ID: NCT01195259
Status: COMPLETED
Last Update Posted: 2013-10-28
First Post: 2010-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Malignancy Meta Analysis for BRL49653
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rosiglitazone View
None ADOPT View
None metformin View
None malignancy View
None RECORD View